An Australian stem cell and regenerative medicine company

July 25, 2023

Cynata provides Ausbiz’s Small Caps a clinical trials update

Having recently completed a strategic review of its clinical development portfolio under the new leadership of Dr Kilian Kelly, CEO & Managing Director, he outlines to Ausbiz what investors can expect from the Cynata in the near and long-term. Watch the interview here (start at 18.37)